957205-74-2 Usage
Uses
Used in Pharmaceutical Industry:
(3-methyl-4-trifluoromethylphenyl)methanol is utilized as a building block for the synthesis of pharmaceutical drugs. Its unique chemical structure allows it to be a key component in the development of new medications, contributing to the advancement of healthcare and treatment options.
Used in Agrochemical Industry:
In the agrochemical sector, (3-methyl-4-trifluoromethylphenyl)methanol serves as a building block for the synthesis of crop protection products. Its incorporation into these products can enhance their effectiveness in protecting crops from pests and diseases, thereby supporting agricultural productivity and food security.
Used in Material Development:
(3-methyl-4-trifluoromethylphenyl)methanol has been studied for its potential use in the development of new materials. Its distinctive properties may contribute to the creation of innovative materials with applications in various industries, including electronics, automotive, and aerospace.
Used as a Reagent in Organic Synthesis:
Furthermore, (3-methyl-4-trifluoromethylphenyl)methanol functions as a reagent in organic synthesis. Its versatility in chemical reactions makes it valuable for the production of a wide range of organic compounds, expanding the scope of chemical research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 957205-74-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,2,0 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 957205-74:
(8*9)+(7*5)+(6*7)+(5*2)+(4*0)+(3*5)+(2*7)+(1*4)=192
192 % 10 = 2
So 957205-74-2 is a valid CAS Registry Number.
957205-74-2Relevant academic research and scientific papers
HETEROARYLAMIDE LOWER CARBOXYLIC ACID DERIVATIVE
-
Page/Page column 172, (2009/02/10)
To provide a novel compound which has S1P receptor agonistic activity, exhibits excellent immunosuppressing effect, gives less adverse side effects, and can be orally administered. The invention provides a compound represented by general formula (I) (wherein A is a single bond, -O-, or - CH2-; R1 represents a hydrogen atom or a C1-C6 alkyl group, and V represents any one group selected from among the following groups (1) to (3) : (1) -G1-, (2) -G2-N(R2) -G3-, and (3) a group represented by formula 2, wherein each of Z1 and Z2 represents a hydrogen atom or a C1-C6 alkyl group, Z3 represents a hydrogen or the like, Q represents -CH2-O- or the like, and Y represents a group represented by foumula 3, a salt thereof, or a solvate thereof.
